This is the first report of sequence from Fiji disease fijivirus (FDV), the type member of the genus Fijivirus of the family Reoviridae. FDV genome segment (S9) comprised 1843 nt and contained two non-overlapping ORFs, separated by a 57 nt intergenic region. S9 ORF 1 comprised 1008 nt and encoded a 335-amino-acid polypeptide (predicted molecular mass 38n6 kDa), while ORF 2 comprised 627 nt and encoded a 208-amino-acid polypeptide (predicted molecular mass 23n8 kDa). The 5h and 3h non-coding regions were 49 and 102 nt, respectively. The S9 terminal sequences were 5h AAGU-UUUU------UGUC 3h, and located immediately adjacent to these sequences were 12 bp imperfect inverted repeats. The entire S9 ORF 1 and the
Introduction
Fiji disease of sugarcane, caused by Fiji disease fijivirus (FDV) , is one of the most important diseases of sugarcane (Saccharum L. hybrids) in Queensland. In addition to Australia, the disease also occurs in the Philippines, Thailand and the South Pacific. Infected sugarcane develops characteristic raised, smooth and whitish galls on the undersurface of the leaf blade and midrib (Egan et al., 1989) . Importantly, infected sugarcane often becomes stunted which results in severe yield losses.
FDV has a multipartite genome consisting of 10 linear segments (S1-S10) of double-stranded (ds) RNA ranging in size from approximately 1n8 to 4n4 kbp with a total genome size of approximately 30 kbp (Reddy et al., 1975) . The virus is transmitted vegetatively and by planthoppers of the genus Perkinsiella in a persistent manner (Hutchinson & Francki, 1973) .
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hydrophilic regions of S9 ORF 2 were each expressed as a fusion protein with the maltose-binding protein in Escherichia coli. Antibodies produced against the ORF 1 fusion protein reacted strongly with a protein of approximately 39 kDa present in both crude extracts of FDV-infected sugarcane and partially purified FDV preparations. In contrast, antibodies raised against the modified ORF 2 fusion protein did not react with any proteins in the same samples. Further, polyclonal antibodies produced against partially purified FDV reacted with the ORF 1, but not the modified ORF 2, fusion protein. These results indicate that FDV S9 ORF 1 encodes a major structural protein, while ORF 2 probably encodes a non-structural protein.
Plant-infecting members of the family Reoviridae are classified into three genera, Phytoreovirus, Fijivirus and Oryzavirus, based on the number and size of genome segments and their electrophoretic profile, virion morphology, serology and the insect vectors (Nuss & Dall, 1990) . FDV is the sole member of serogroup 1 of the genus Fijivirus (Holmes et al., 1995) . Other fijiviruses include maize rough dwarf (MRDV), rice black-streaked dwarf (RBSDV), pangola stunt (all belonging to serogroup 2), and oat sterile dwarf (serogroup 3). The nucleotide sequences of several genome segments from different fijiviruses belonging to serogroups 2 and 3 have been published (Uyeda et al., 1990 ; Marzachi et al., 1991 ; Azuhata et al., 1993) . However, sequence data on FDV have been limited to primer sequences for use in PCR-based diagnostics (Smith et al., 1992) . This paper reports the first genomic nucleotide sequence of FDV, that of segment 9, and the characterization of the encoded putative gene products.
Methods
DsRNA extraction and Northern blotting. FDV dsRNA was extracted from FDV-infected sugarcane as described by Dale et al. (1986) . The dsRNA was electrophoresed through 1 % agarose gels and blotted 0001-5761 # 1998 SGM DBFF H. M. Soo and others H. M. Soo and others onto Hybond-N nylon membranes (Amersham) using capillary transfer or PosiBlot (Stratagene) (Karan et al., 1994) .
Identification of FDV S9 clones.
A random-primed FDV cDNA genomic library was prepared using a cDNA synthesis kit (Pharmacia) followed by blunt-end cloning into the SmaI site of pGEM-3Zf(j) (Promega). Recombinant plasmids were purified by alkaline lysis and the inserts were excised by digestion with EcoRI and PstI. Inserts were gelpurified using the BRESA-CLEAN DNA Purification kit (Bresatec), labelled with [α-$#P]dCTP using the High Prime kit (Boehringer Mannheim), and used to probe Northern blots of FDV dsRNA using the Rapid-hyb buffer (Amersham).
Clones that hybridized to FDV S9 or S10 were digested with EcoRI and PstI, separated on a 1 % agarose gel, and directly transferred by PosiBlot using 0n4 M NaOH (Reed & Mann, 1985) onto nylon membrane (Boehringer Mannheim). A 1n6 kbp insert from a previously characterized S10-specific clone, S10.5 (P. S. Burns, J. A. Handley, G. R. Smith, J. L. Dale & R. M., Harding, unpublished results), was gel-purified, labelled, and used to probe the Southern blot as described for Northern analysis. Inserts from S9-specific clones were sequenced using an automated DNA sequencer (model 373A, Applied Biosystems) using the universal M13 forward and reverse primers.
PCR.
The approximate locations of the clones and the primers used in FDV cDNA synthesis and PCR are given in Fig. 1 . Unless otherwise stated, all PCRs were done using the PCR buffer provided in a final volume of 50 µl containing 1 µl of FDV cDNA (see below), 10 pmol of each primer, 200 µM of each dNTP and 1 unit of Pwo DNA polymerase (Boehringer Mannheim). Standard 35 cycle procedures were used for PCR, and the products were analysed using 1-2 % agarose gels.
Amplification and cloning of the FDV S9 5h sequence. The terminal sequences were amplified using anchor-ligated PCR (Lambden et al., 1992 ; Bigot et al., 1995) . RNase was removed from the FDV dsRNA preparation by treatment with proteinase K (Sambrook et al., 1989) . A 200 ng aliquot of primer 1 (CCCCGGGATCCTGCAGAATTCT-NH # ) was ligated to 200 ng of FDV dsRNA using T4 RNA ligase at 4 mC overnight in a final volume of 10 µl. Following denaturation at 99 mC for 90 s, 90 ng of primer 2 (the complementary sequence of primer 1) was added and cDNA was synthesized using Superscript II reverse transcriptase (Life Technologies) according to the manufacturer's instructions. In a separate reaction, S9.p1 was used to prime cDNA from 100 ng of FDV dsRNA. The two DNA-RNA hybrids were hydrolysed in 0n1 M NaOH, neutralized in 0n1 M HCl, and the two sscDNAs were annealed overnight at 65 mC. The partial duplex was repaired and amplified using 2n5 units of Taq DNA polymerase (Perkin Elmer), 10 pmol of S9.p1 and 30 pmol of primer 2. PCR products were ligated into the pGEM-T vector (Promega) and transformed into Escherichia coli DH5α cells.
Amplification and cloning of the S9 3h sequence. Primer 1 was ligated to FDV dsRNA and cDNA was synthesized using primer 2 as described above, except that the cDNA was generated at 55 mC. The 3h sequence was amplified from this cDNA using primer S9.p4 and primer 2. PCR products were digested with BamHI, ligated into SmaI\BamHI-digested pGEM-3Zf(j) and transformed into E. coli DH5α cells.
Sequence analysis. Sequence data were assembled and analysed using the GCG programs (Program Manual for the Wisconsin Package, version 8, August 1994, Genetics Computer Group, Madison, WI, USA). The FDV S9 inverted repeats were identified using the SQUIGGLES program. The hydrophobicity and antigenicity plots of S9 ORF 2 were determined using the PLOTSTRUCTURE program. Databases were searched using the FASTA (Pearson, 1990) and BLAST (Altschul et al., 1990) programs.
Cloning and expression of FDV S9 ORF 1 and ORF 2. The FDV S9 ORF 1 and modified ORF 2 polypeptides were expressed in E. coli as fusion proteins with the maltose-binding protein (MBP) using the pMAL-c2 expression vector (New England Biolabs). The entire ORF 1 of S9 was amplified using primers S9.pA and S9.pB from S9-specific cDNA synthesized using primer S9.pA. PCR products were digested with BamHI, ligated into XmnI\BamHI-digested pMAL-c2 vector (NEB), and transformed into E. coli DH5α cells. Recombinants were selected and sequenced using the malE and universal forward primers. The MBP-ORF 1 fusion protein was produced and purified as described by the manufacturer. Briefly, cells were induced with 0n3 mM IPTG for 2 h and resuspended in column buffer (20 mM Tris-HCl, pH 7n4, 200 mM NaCl, 1 mM EDTA). The MBP-ORF 1 fusion protein was released from the cells by sonication, collected in the supernatant, and purified by amylose affinity column chromatography.
The S9 modified ORF 2 was amplified in two stages. Initially, S9-specific cDNA was synthesized using primer S9.pC. Primer pairs S9.pC\S9.p5 and S9.p6\S9.pD were then used to amplify the first 233 and last 283 nt of ORF 2, respectively. PCR products were digested with HindIII, ligated and used as a template for amplification with primers S9.pC and S9.pD. The final PCR products were digested with EcoRI, ligated into XmnI-EcoRI-digested pMAL-c2 vector, and transformed into E. coli DH5α cells. Selection of recombinants and the production and purification of the MBP-modified ORF 2 fusion protein was as described above. The purified fusion proteins from both ORFs were cleaved with 2% (w\w) factor Xa protease (NEB). FDV S9 encodes two proteins FDV S9 encodes two proteins Western blot analysis. Proteins were transferred from polyacrylamide gels onto nitrocellulose membranes (Schleicher and Schuell) using a Mini Trans-Blot cell (Bio-Rad) in buffer containing 10 mM CAPS, pH 11n0, 10 % methanol and 0n001 % SDS. The blotted fusion proteins and S9 ORF polypeptides were reacted with polyclonal antibodies against MBP (NEB) or partially purified FDV particles. Bound antibodies were detected with peroxidase-conjugated swine anti-rabbit IgG (Dako) and BM Chemiluminescence blotting substrate (POD) (Boehringer Mannheim).
DBFG
Antibody preparation. Polyclonal antibodies to the MBP-ORF 1 and MBP-modified ORF 2 fusion proteins were raised in 10-week-old New Zealand White rabbits. Three intramuscular injections were given at 10 day intervals, each consisting of approximately 0n3 mg purified fusion protein emulsified with an equal volume of Freund's incomplete adjuvant. Serum samples were collected 10 days after the final inoculation and were tested by Western blot analysis using purified fusion proteins, crude extracts from healthy and FDV-infected sugarcane and partially purified FDV particles.
Preparation of crude plant extracts and FDV particles.
Crude extracts from healthy and FDV-infected sugarcane were prepared as described by Rohozinski et al. (1981) . FDV particles were purified from FDV-infected gall tissue using a combination of methods from Ikegami & Francki (1974) and Hatta & Francki (1976) and were resuspended in 50-100 µl STE buffer.
Results and Discussion

Identification of FDV S9-specific clones
Recombinant plasmids from the FDV genomic library were purified and 20 clones had inserts between 500-800 bp. These inserts were labelled and used as probes in Northern analysis using purified FDV dsRNA. Five clones that hybridized to either FDV S9 or S10 were identified (data not shown). The exact segment specificity of the clones could not be accurately determined because FDV S9 and S10 could not be sufficiently resolved by agarose or polyacrylamide gel electrophoresis due to their similar size. Therefore, the segment specificity of the clones was determined by Southern analysis using a previously characterized S10-specific clone, S10.5, as a probe. The insert from this clone represented approximately 90 % of the S10 sequence. In Southern analysis, the labelled insert from S10.5 did not hybridize to four of the clones, implying that these clones contained S9-specific sequences.
The inserts from these four clones (clones A, B, C and D, Fig. 1 ) were sequenced in both directions. When the sequences were aligned and compared, a contiguous sequence of 1128 bp, representing approximately 63 % of FDV S9 (approximately 1n8 kbp), was obtained.
Determination of the FDV S9 terminal sequences
To obtain the remainder of FDV S9, a 3h-amino blocked primer (primer 1) was ligated to the 3h ends of the FDV dsRNA. Total FDV cDNA was then synthesized using a second primer (primer 2) complementary to primer 1, and the terminal sequences were subsequently amplified by PCR using a combination of primer 2 and either primer S9.p1 or S9.p4. Primer S9.p1 was designed to anneal 73 nt from the 5h end of the known sequence while S9.p4 was designed to anneal 143 bp from the 3h end of the known sequence.
When primers 2 and S9.p4 were used in a PCR, a major product of approximately 200 bp was amplified and cloned. Two clones which contained the expected-size inserts were sequenced. Both clones contained identical inserts of 181 bp with the expected primer sequences at the 5h and 3h ends. When the sequences were aligned with the known S9 sequence, there was an overlap of 143 bp as expected. The sequence, … UGUC 3h, immediately preceded the primer 1 sequence and represented the S9 3h-terminal sequence. The 5h-terminal sequence was obtained using primers 2 and S9.p1. A major product of approximately 800 bp was amplified and cloned. Again, two clones which contained inserts of the expected size were sequenced. Both clones contained identical sequences comprising 794 bp with the expected primer sequences at the 5h and 3h ends. When the sequences were aligned with the known S9 sequence, there was an overlap of 73 bp as expected. The sequence, 5h AAGUUUUU …, was found immediately after the primer 2 sequence and represented the S9 5h-terminal sequence.
The 3h-terminal sequence of FDV S9 was identical to those of the related fijiviruses RBSDV and MRDV (Azuhata et al., 1992 ; Marzachi et al., 1991) . Marzachi et al. (1995) proposed conserved 5h-and 3h-terminal sequences for all members of the genus Fijivirus based on the conserved terminal sequences of MRDV and RBSDV. However, the 5h-terminal sequence of FDV differed from those of MRDV and RBSDV by an A instead of a U at position 9. Therefore, the proposed 5h conserved fijivirus terminal sequence may now need to be revised. Conserved 5h and 3h sequences have been found in all reoviruses sequenced to date, with genus-specific conserved terminal sequences though to act as a packaging signal for viral and not host DNA (Anzola et al., 1987) .
Genomic analysis of FDV S9
The complete cDNA sequence of FDV S9 was assembled and analysed using GCG programs. FDV S9 was 1843 nt and contained two non-overlapping ORFs separated by a 57 nt intergenic region (Fig. 2 a) . S9 had a GC content of 32n8 %. ORF 1 was 1008 nt (nt 50-1057) and potentially encoded a 335-amino-acid protein with a calculated molecular mass of 38 580 Da. Two in-frame start codons were identified in ORF 1 at nt 50-52 and 53-55. The second ATG was presumed to be the true start codon because it contained the consensus sequence for translational initiation by eukaryotic ribosomes (Kozak, 1981 (Kozak, , 1986 . ORF 2 comprised 627 nt (nt 1115-1741) and potentially encoded a 208-amino-acid protein with a calculated molecular mass of 23 835 Da. Both MRDV and RBSDV have at least two segments which contain a similar genome organization (Marzachi et al., 1995) . The 5h and 3h non-coding regions of S9 were 49 and 102 nt, respectively, while a 12 bp imperfect inverted repeat was identified immediately adjacent to the S9 terminal sequences (Fig. 2 b) . Segment-specific inverted repeats have been found in all reovirus sequences and may act as a signal to specify a particular segment (Anzola et al., 1987) .
Comparison of the FDV S9 sequence to other sequences revealed 54n9 % similarity, at the nucleotide level, with segment 8 (S8) of the related fijivirus, MRDV. At the amino acid level, FDV S9 ORF 1 and MRDV S8 ORF 1 had 56n8 % similarity and 37n4 % identity, while FDV S9 ORF 2 and MRDV S8 ORF 2 had 62n2 % similarity and 41n3 % identity.
DBFI FDV S9 encodes two proteins FDV S9 encodes two proteins Fig. 3 . Western blot analysis of MBP-ORF 1 (lanes 1, 2, 6 and 7) and MBP-ORF 2 (lanes 8, 9 and 13). The blotted proteins were probed with the following polyclonal antibodies : anti-ORF 1 (lanes 1-5) , anti-ORF 2 (lane 13) and anti-FDV (lanes 6-12). Lanes 1, 6 and 8, purified fusion proteins ; lanes 2, 7, 9 and 13, factor Xa-digested fusion proteins ; lanes 3 and 10, crude extracts from healthy sugarcane ; lanes 4 and 11, crude extracts from FDV-infected sugarcane ; lanes 5 and 12, purified FDV particles. Digitally generated images were prepared using HP Deskscan II (version 2.5) with a Scanjet 11cx scanner.
Characterization of the FDV S9 ORF 1 polypeptide
To determine the function of the proteins encoded by the two ORFs of S9, each was expressed as a fusion protein with MBP. The entire ORF 1 was amplified and cloned into pMALc2. Five clones contained inserts of the expected size. The integrity of the insert from one clone, pMAL-81, was confirmed by sequencing. Upon induction, pMAL-81 expressed high levels of an 81 kDa protein which was not present in a similarly induced E. coli culture containing the native vector. The size of this protein was consistent with the predicted molecular mass of the MBP-ORF 1 fusion protein (MBP 43 kDa, ORF 1 polypeptide 38n6 kDa). When the fusion protein was purified and digested with factor Xa two main bands corresponding to 43 kDa (MBP) and 38 kDa (ORF 1) were observed. A minor band of 81 kDa was also observed, suggesting incomplete digestion with factor Xa. In Western blot analysis of the digested fusion protein, both the 81 and 43 kDa proteins reacted with anti-MBP antibodies (data not shown), confirming that the 81 kDa protein was the MBP-ORF 1 fusion protein and the 43 kDa protein was MBP.
To study the gene product of FDV S9 ORF 1 further, antibodies were raised against the S9 fusion protein in a rabbit. The fusion protein was highly antigenic, with antibody titre increasing with progressive injections. The specificity of the antiserum was evaluated by Western blot analysis using the fusion protein, crude healthy and FDV-infected sugarcane extracts, and purified FDV particles. The antibodies were able to detect the fusion protein at a dilution of more than 10 000-fold. Further, the antibodies reacted strongly and specifically with the 38 kDa band from the factor Xa-cleaved fusion protein, and to a band of approximately 40 kDa present in crude FDV-infected sugarcane extracts and purified FDV particles (Fig. 3, lanes 2, 4 and 5, respectively) . No reaction to healthy sugarcane extracts was observed. Western blot analysis of the same samples using anti-FDV antibodies produced identical results (Fig. 3, lanes 7, 11 and 12 , respectively).
Three structural proteins (145) (146) (147) (148) (149) (150) (125) (126) (127) (128) (129) (36) (37) (38) (39) have been previously identified from partially purified FDV ( Van der Lubbe et al., 1979) . However, in Western blot analysis of partially purified FDV using anti-FDV antibodies, four faint bands and one very strong band (" 39 kDa) were identified, suggesting that at least five proteins were associated with the virions. The antibodies produced against the FDV S9 ORF 1 fusion protein reacted strongly and specifically with the 39 kDa protein present in partially purified FDV preparations, indicating that S9 ORF 1 encodes a structural protein of 38 kDa. S9 of rice ragged stunt oryzavirus (RRSV) also encodes a highly immunogenic major structural protein of 38 kDa which is thought to be a spike protein (Upadhyaya et al., 1995) . Despite the lack of homology between the FDV and RRSV S9 sequences, it is possible that FDV S9 ORF 1 may also encode a spike protein, based on size and genome location. Immunogold labelling studies using purified intact and subviral FDV may help determine the exact location of this protein.
Characterization of FDV S9 ORF 2 polypeptide
Initially, attempts were made to produce a fusion protein comprising the entire S9 ORF 2. Despite numerous attempts, no clones containing the expected-sized inserts were obtained, suggesting that the fusion protein encoded by ORF 2 was toxic to E. coli. As an alternative strategy, the hydrophilic, and supposedly antigenic, regions of the ORF 2-encoded protein were identified and used to produce a fusion protein. A hydrophobicity plot of ORF 2 revealed a central hydrophobic region comprising approximately 70 amino acids, flanked by hydrophilic amino and carboxy termini (data not shown). The DNA sequences encoding the two predicted hydrophilic domains (233 and 288 nt) were subsequently amplified by PCR and ligated in-frame prior to cloning into the pMAL-c2 vector.
Seven clones contained inserts of the expected size. The integrity of the insert from one clone, pMAL-1, was confirmed by sequencing. Upon induction with IPTG, pMAL-1 expressed high levels of a 60 kDa protein which was not found in a DBFJ similarly induced E. coli culture containing the native pMAL-c2 vector. The size of this protein was consistent with the predicted molecular mass of the MBP-modified ORF 2 fusion protein (MBP 43 kDa, modified ORF 2 polypeptide 17n5 kDa). When the fusion protein was purified and digested with factor Xa, two main bands corresponding to 43 and 17 kDa were observed. A minor band of 60 kDa was also observed, suggesting incomplete digestion with factor Xa.
Antibodies were raised against the fusion protein in a rabbit. In Western blot analysis, these antibodies strongly reacted to the 43 kDa MBP band, but very weakly with the 17 kDa modified ORF 2 polypeptide band from the factor Xacleaved fusion protein (Fig. 3, lane 13) . The antibodies were unable to detect the 17 kDa band at a dilution of more than 500-fold. Further, the antibodies did not react with any protein in either the crude healthy and FDV-infected sugarcane extracts or purified FDV particles (data not shown). In addition, the anti-FDV antibodies did not detect the 17 kDa modified ORF 2 polypeptide band in Western blot analysis of the factor Xacleaved fusion protein, although a very faint reaction to the 43 kDa MBP band was observed (Fig. 3, lanes 8 and 9) . These results suggested that FDV S9 ORF 2 encoded a non-structural protein. In addition, the size of the putative protein encoded by the entire S9 ORF 2 (23n8 kDa) was not identified by Van der Lubbe et al. (1979) in protein studies with partially purified FDV. It is possible, however, that the lack of reaction between the anti-ORF 2 antibodies and the above samples may have been due to the removal of the central hydrophobic region from the native ORF 2 protein.
